MiXCR - About the company
MiXCR is an unfunded company based in San Francisco (United States), founded in 2021 by Stanislav Poslavsky and Alexey Nechaev. It operates as a Provider of a comprehensive analysis solution for Next-Generation Sequencing data. MiXCR has not raised any funding yet. The company has 393 active competitors, including 76 funded and 33 that have exited. Its top competitors include companies like Hexagon Bio, Deep Genomics and BC Platforms.
Company Details
Provider of a comprehensive analysis solution for Next-Generation Sequencing data. It offers a software suite for comprehensive analysis of T-cell and B-cell receptor repertoires from high-throughput sequencing data.
- Website
- mixcr.com
Key Metrics
Founded Year
2021
Location
San Francisco, United States
Stage
Unfunded
Ranked
123rd among 393 active competitors
Similar Companies
Sign up to download MiXCR's company profile
MiXCR's funding and investors
MiXCR has not raised any funding rounds yet.
MiXCR's founders and board of directors
Founder? Claim ProfileThe founders of MiXCR are Stanislav Poslavsky and Alexey Nechaev. Stanislav Poslavsky is the CEO of MiXCR.
Here are the details of MiXCR's key team members:
- Stanislav Poslavsky: Co-Founder & CEO of MiXCR and founder of 2 other companies, Platforma.bio and MiLaboratories. Contact Info: 3 email addresses
- Alexey Nechaev: Co-Founder & COO of MiXCR.
View details of MiXCR's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
MiXCR's Competitors and alternates
Top competitors of MiXCR include Hexagon Bio, Deep Genomics and BC Platforms. Here is the list of Top 10 competitors of MiXCR, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Hexagon Bio 2017, Menlo Park (United States), Series B | Provider of bioinformatics tools for the analysis of microbial genomic sequencing data | $206M | 62/100 | |
2nd |  Deep Genomics 2014, Toronto (Canada), Series C | AI-powered platform for RNA biology to accelerate genetic therapy discovery | $238M | 62/100 | |
3rd | BC Platforms 1997, Zurich (Switzerland), Series D | Provider of a platforms for genomic data analysis and management | $47.1M | 58/100 | |
4th | Provider of bioinformatics tools for the analysis of genome sequencing data | $48.8M | 57/100 | ||
5th |  Linus Biotechnology 2020, New York City (United States), Series A | Developer of diagnostic tests for central nervous system and gastrointestinal disorders | $47.6M | 55/100 | |
6th |  Broken String Biosciences 2020, Cambridge (United Kingdom), Series A | Developer of biopharmaceutical products & cell therapies by using genome sequencing data | $15M | 55/100 | |
7th |  OutSee United Kingdom, Seed | Developer of an artificial intelligence engine for predictive genomics | $5.79M | 54/100 | |
8th |  Zetta Genomics 2018, Worcester (United Kingdom), Seed | Provider of genomic data analysis software for clinical labs & research organizations | $10.4M | 54/100 | |
9th | Provider of AI-based platform for drug discovery and design | $11.7M | 53/100 | ||
10th | Provider of solutions for single-molecule genetic and epigenetic sequencing | $47M | 51/100 | ||
123rd | MiXCR 2021, San Francisco (United States), Unfunded | Provider of a comprehensive analysis solution for Next-Generation Sequencing data | - | - | 30/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on MiXCR's competitors? Click here to see the top ones
MiXCR's Investments and acquisitions
MiXCR has made no investments or acquisitions yet.
Reports related to MiXCR
Here is the latest report on MiXCR's geography:
Are you a Founder ?
FAQs about MiXCR
Explore our recently published companies
- Pilot-Projects - 2009 founded, Unfunded company
- Nextearthproductions - Unfunded company
- Zakti - Unfunded company
- Valorium - Unfunded company
- Swiftadvisory - Unfunded company
- Winstanley-Consulting - Unfunded company
